In focus
Latest feed
A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition
Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients
FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary
Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape
